Synthesis and biological evaluation of new potent and selective HCV NS5A inhibitors-Reference-Cited by-同舟云学术

Synthesis and biological evaluation of new potent and selective HCV NS5A inhibitors

Published:2012-05 Issue:10 Volume:22 Page:3488-3491
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Shi Junxing,Zhou Longhu,Amblard Franck,Bobeck Drew R.,Zhang Hongwang,Liu Peng,Bondada Lavanya,McBrayer Tamara R.,Tharnish Phillip M.,Whitaker Tony,Coats Steven J.,Schinazi Raymond F.

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference18 articles.

1. Epidemiology of Hepatitis C: Geographic Differences and Temporal Trends

2. Natural history of chronic hepatitis C

3. Hepatitis C: progress and problems

4. Natural history of hepatitis C: Its impact on clinical management

5. New therapeutic strategies for hepatitis C

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Flow synthesis approaches to privileged scaffolds – recent routes reviewed for green and sustainable aspects;Green Chemistry;2021

2. Discovery and Characterization of Potent Pan-Genotypic HCV NS5A Inhibitors Containing Novel Tricyclic Central Core Leading to Clinical Candidate;Journal of Medicinal Chemistry;2019-11-11

3. Ferrocene-based inhibitors of hepatitis C virus replication that target NS5A with low picomolar in vitro antiviral activity;Bioorganic & Medicinal Chemistry Letters;2018-11

4. Sulfur(vi) fluoride exchange as a key reaction for synthesizing biaryl sulfate core derivatives as potent hepatitis C virus NS5A inhibitors and their structure–activity relationship studies;RSC Advances;2018

5. Synthesis and evaluation of novel HCV replication inhibitors;Molecular Diversity;2017-03-14